nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—CYP1A2—urine—bipolar disorder	0.0806	0.137	CbGeAlD
Pomalidomide—CRBN—adrenal cortex—bipolar disorder	0.065	0.111	CbGeAlD
Pomalidomide—CYP3A4—urine—bipolar disorder	0.0583	0.0994	CbGeAlD
Pomalidomide—CRBN—thyroid gland—bipolar disorder	0.0452	0.0771	CbGeAlD
Pomalidomide—CYP1A2—blood plasma—bipolar disorder	0.0421	0.0717	CbGeAlD
Pomalidomide—CRBN—nervous system—bipolar disorder	0.0381	0.0649	CbGeAlD
Pomalidomide—CRBN—cerebellum—bipolar disorder	0.0358	0.061	CbGeAlD
Pomalidomide—PTGS2—blood plasma—bipolar disorder	0.0348	0.0594	CbGeAlD
Pomalidomide—CYP3A4—blood plasma—bipolar disorder	0.0304	0.0519	CbGeAlD
Pomalidomide—CRBN—brain—bipolar disorder	0.0291	0.0496	CbGeAlD
Pomalidomide—ABCB1—blood plasma—bipolar disorder	0.0216	0.0367	CbGeAlD
Pomalidomide—TNF—Matrix Metalloproteinases—MMP16—bipolar disorder	0.0209	0.0505	CbGpPWpGaD
Pomalidomide—PTGS2—adrenal cortex—bipolar disorder	0.0177	0.0301	CbGeAlD
Pomalidomide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C4—bipolar disorder	0.016	0.0388	CbGpPWpGaD
Pomalidomide—CYP1A2—thyroid gland—bipolar disorder	0.0149	0.0254	CbGeAlD
Pomalidomide—TNF—Monoamine Transport—TPH2—bipolar disorder	0.0128	0.0309	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—GATA3—bipolar disorder	0.0121	0.0292	CbGpPWpGaD
Pomalidomide—ABCB1—adrenal cortex—bipolar disorder	0.0109	0.0186	CbGeAlD
Pomalidomide—PTGS2—nervous system—bipolar disorder	0.0104	0.0177	CbGeAlD
Pomalidomide—TNF—Monoamine Transport—SLC6A4—bipolar disorder	0.0102	0.0247	CbGpPWpGaD
Pomalidomide—PTGS2—cerebellum—bipolar disorder	0.00975	0.0166	CbGeAlD
Pomalidomide—TNF—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.00971	0.0235	CbGpPWpGaD
Pomalidomide—TNF—Monoamine Transport—SLC6A3—bipolar disorder	0.0091	0.022	CbGpPWpGaD
Pomalidomide—CYP3A4—nervous system—bipolar disorder	0.00905	0.0154	CbGeAlD
Pomalidomide—TNF—Transcription factor regulation in adipogenesis—NR3C1—bipolar disorder	0.00883	0.0214	CbGpPWpGaD
Pomalidomide—PTGS2—brain—bipolar disorder	0.00792	0.0135	CbGeAlD
Pomalidomide—ABCB1—thyroid gland—bipolar disorder	0.00762	0.013	CbGeAlD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—bipolar disorder	0.00714	0.0173	CbGpPWpGaD
Pomalidomide—CYP1A2—Methylation—COMT—bipolar disorder	0.00687	0.0166	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—GRIN1—bipolar disorder	0.0068	0.0165	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—NCAN—bipolar disorder	0.00651	0.0158	CbGpPWpGaD
Pomalidomide—ABCB1—nervous system—bipolar disorder	0.00641	0.0109	CbGeAlD
Pomalidomide—ABCB1—cerebellum—bipolar disorder	0.00603	0.0103	CbGeAlD
Pomalidomide—TNF—Alzheimers Disease—CACNA1C—bipolar disorder	0.00567	0.0137	CbGpPWpGaD
Pomalidomide—TNF—Cellular roles of Anthrax toxin—IL1B—bipolar disorder	0.00501	0.0121	CbGpPWpGaD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.00496	0.012	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—GRIN1—bipolar disorder	0.00494	0.0119	CbGpPWpGaD
Pomalidomide—ABCB1—brain—bipolar disorder	0.0049	0.00835	CbGeAlD
Pomalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NRG1—bipolar disorder	0.00464	0.0112	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—HLA-E—bipolar disorder	0.00458	0.0111	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—NRG1—bipolar disorder	0.0045	0.0109	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TACR1—bipolar disorder	0.00449	0.0109	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—GRIN2B—bipolar disorder	0.00448	0.0108	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—bipolar disorder	0.00442	0.0107	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—IL1B—bipolar disorder	0.00438	0.0106	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—MTHFR—bipolar disorder	0.00431	0.0104	CbGpPWpGaD
Pomalidomide—CYP1A2—Estrogen metabolism—COMT—bipolar disorder	0.00429	0.0104	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL1B—bipolar disorder	0.00425	0.0103	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—GSK3B—bipolar disorder	0.00406	0.00981	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—NCAN—bipolar disorder	0.00403	0.00974	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.00395	0.00955	CbGpPWpGaD
Pomalidomide—TNF—Monoamine Transport—IL1B—bipolar disorder	0.00371	0.00898	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.0036	0.0087	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.0036	0.0087	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—MTHFR—bipolar disorder	0.0035	0.00848	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—MAD1L1—bipolar disorder	0.00343	0.0083	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—INS—bipolar disorder	0.00343	0.00829	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—GATA3—bipolar disorder	0.00333	0.00805	CbGpPWpGaD
Pomalidomide—CYP3A4—Estrogen metabolism—COMT—bipolar disorder	0.00331	0.00801	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—IL1B—bipolar disorder	0.0033	0.00799	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—GSK3B—bipolar disorder	0.00327	0.00791	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—ADM—bipolar disorder	0.00322	0.00779	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—NRG1—bipolar disorder	0.00321	0.00776	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—GRIN1—bipolar disorder	0.00305	0.00738	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.00298	0.0072	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.00293	0.00709	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—GATA3—bipolar disorder	0.00292	0.00706	CbGpPWpGaD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—MAOA—bipolar disorder	0.00291	0.00704	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00287	0.00695	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00287	0.00695	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00287	0.00695	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.0028	0.00676	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—INS—bipolar disorder	0.00279	0.00674	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—MTHFR—bipolar disorder	0.00278	0.00673	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TACR1—bipolar disorder	0.00278	0.00673	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.00278	0.00672	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—BDNF—bipolar disorder	0.00261	0.00631	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL1B—bipolar disorder	0.00256	0.00618	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—GSK3B—bipolar disorder	0.00245	0.00592	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.00236	0.0057	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—GSK3B—bipolar disorder	0.00233	0.00564	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—INS—bipolar disorder	0.00221	0.00536	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00216	0.00523	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—NTRK1—bipolar disorder	0.00215	0.0052	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—NR3C1—bipolar disorder	0.00213	0.00516	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00209	0.00505	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL1B—bipolar disorder	0.00208	0.00503	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NCAN—bipolar disorder	0.00207	0.00501	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—ANK3—bipolar disorder	0.00203	0.00491	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-E—bipolar disorder	0.00201	0.00486	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—BDNF—bipolar disorder	0.00197	0.00476	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.00194	0.00469	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00194	0.00468	CbGpPWpGaD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00191	0.00462	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00184	0.00446	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—IL1B—bipolar disorder	0.0018	0.00436	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL1B—bipolar disorder	0.0018	0.00436	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.00177	0.00429	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00176	0.00427	CbGpPWpGaD
Pomalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—bipolar disorder	0.00174	0.0042	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—MTHFR—bipolar disorder	0.00172	0.00416	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL1B—bipolar disorder	0.00165	0.004	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—INS—bipolar disorder	0.00162	0.00392	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—BDNF—bipolar disorder	0.00161	0.0039	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GRIN1—bipolar disorder	0.00157	0.0038	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TRPC3—bipolar disorder	0.00154	0.00372	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00149	0.00361	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL1B—bipolar disorder	0.00147	0.00355	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.00146	0.00353	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—CACNB2—bipolar disorder	0.00143	0.00346	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—INS—bipolar disorder	0.00137	0.00331	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00133	0.00322	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00132	0.00319	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00132	0.00318	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—CACNA1C—bipolar disorder	0.00131	0.00316	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—bipolar disorder	0.00131	0.00316	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.00121	0.00292	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.0012	0.0029	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.0012	0.00289	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—bipolar disorder	0.00115	0.00277	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.0011	0.00266	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—IMPA2—bipolar disorder	0.00107	0.00258	CbGpPWpGaD
Pomalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00106	0.00256	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00104	0.00253	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GRIN2B—bipolar disorder	0.00103	0.0025	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.00103	0.0025	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—bipolar disorder	0.00102	0.00247	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00102	0.00246	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—bipolar disorder	0.000985	0.00238	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.000971	0.00235	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000858	0.00208	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.00085	0.00206	CbGpPWpGaD
Pomalidomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000817	0.00198	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00081	0.00196	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—bipolar disorder	0.000808	0.00195	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—bipolar disorder	0.00079	0.00191	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000778	0.00188	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—IMPA2—bipolar disorder	0.000756	0.00183	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000755	0.00183	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000754	0.00182	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—IMPA1—bipolar disorder	0.00072	0.00174	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKR1C4—bipolar disorder	0.000708	0.00171	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—COMT—bipolar disorder	0.000705	0.00171	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000704	0.0017	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—MAOA—bipolar disorder	0.0007	0.00169	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	0.000695	0.00168	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000677	0.00164	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000662	0.0016	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NDUFV2—bipolar disorder	0.000612	0.00148	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCAN—bipolar disorder	0.000608	0.00147	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—IMPA2—bipolar disorder	0.000603	0.00146	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC5A3—bipolar disorder	0.000596	0.00144	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKR1C4—bipolar disorder	0.000593	0.00143	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000573	0.00139	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GSK3B—bipolar disorder	0.000565	0.00137	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—bipolar disorder	0.000557	0.00135	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000544	0.00132	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.00054	0.00131	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000537	0.0013	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NR1D1—bipolar disorder	0.000533	0.00129	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—IMPA1—bipolar disorder	0.00051	0.00124	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NCAN—bipolar disorder	0.00051	0.00123	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC5A3—bipolar disorder	0.000499	0.00121	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000466	0.00113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000459	0.00111	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—bipolar disorder	0.000456	0.0011	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NDUFV2—bipolar disorder	0.000434	0.00105	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKR1C4—bipolar disorder	0.00042	0.00102	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—IMPA1—bipolar disorder	0.000408	0.000986	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000398	0.000964	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000379	0.000918	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NR1D1—bipolar disorder	0.000378	0.000914	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000377	0.000911	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCAN—bipolar disorder	0.000361	0.000874	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CLOCK—bipolar disorder	0.000361	0.000873	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC5A3—bipolar disorder	0.000354	0.000856	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000352	0.000851	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TSHB—bipolar disorder	0.000352	0.000851	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TPH2—bipolar disorder	0.000352	0.000851	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNB2—bipolar disorder	0.000352	0.000851	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NDUFV2—bipolar disorder	0.000347	0.000838	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DPYD—bipolar disorder	0.000346	0.000837	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SNAP25—bipolar disorder	0.000336	0.000812	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKR1C4—bipolar disorder	0.000336	0.000812	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GSK3A—bipolar disorder	0.000324	0.000783	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNA1C—bipolar disorder	0.000322	0.000778	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.000315	0.000761	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3C2A—bipolar disorder	0.000313	0.000758	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000309	0.000748	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NR1D1—bipolar disorder	0.000301	0.000729	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADCY2—bipolar disorder	0.000297	0.000719	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TCF7L2—bipolar disorder	0.000296	0.000716	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCAN—bipolar disorder	0.000288	0.000698	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC5A3—bipolar disorder	0.000282	0.000683	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SNAP25—bipolar disorder	0.000281	0.00068	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000267	0.000647	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000259	0.000627	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CLOCK—bipolar disorder	0.000256	0.000619	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TSHB—bipolar disorder	0.000249	0.000603	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNB2—bipolar disorder	0.000249	0.000603	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TPH2—bipolar disorder	0.000249	0.000603	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADCY2—bipolar disorder	0.000249	0.000602	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DPYD—bipolar disorder	0.000245	0.000593	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NR1D1—bipolar disorder	0.000233	0.000563	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRG1—bipolar disorder	0.000228	0.000553	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNA1C—bipolar disorder	0.000228	0.000552	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCAN—bipolar disorder	0.000223	0.000538	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3C2A—bipolar disorder	0.000222	0.000538	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC5A3—bipolar disorder	0.000218	0.000527	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COMT—bipolar disorder	0.000213	0.000515	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOA—bipolar disorder	0.000212	0.000512	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—bipolar disorder	0.000206	0.000498	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CLOCK—bipolar disorder	0.000204	0.000494	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SNAP25—bipolar disorder	0.000199	0.000482	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNB2—bipolar disorder	0.000199	0.000481	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TPH2—bipolar disorder	0.000199	0.000481	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TSHB—bipolar disorder	0.000199	0.000481	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DPYD—bipolar disorder	0.000196	0.000474	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNA1C—bipolar disorder	0.000182	0.00044	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	0.000177	0.000429	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADCY2—bipolar disorder	0.000176	0.000427	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000175	0.000423	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—bipolar disorder	0.000172	0.000417	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GSK3B—bipolar disorder	0.000166	0.000401	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—bipolar disorder	0.000164	0.000396	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SNAP25—bipolar disorder	0.000159	0.000385	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CLOCK—bipolar disorder	0.000158	0.000381	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TSHB—bipolar disorder	0.000154	0.000372	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TPH2—bipolar disorder	0.000154	0.000372	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNB2—bipolar disorder	0.000154	0.000372	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DPYD—bipolar disorder	0.000151	0.000366	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COMT—bipolar disorder	0.000151	0.000365	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOA—bipolar disorder	0.00015	0.000363	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADCY2—bipolar disorder	0.000141	0.000341	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNA1C—bipolar disorder	0.00014	0.00034	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—bipolar disorder	0.000138	0.000333	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—bipolar disorder	0.000137	0.000331	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	0.000137	0.000331	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SNAP25—bipolar disorder	0.000123	0.000297	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—bipolar disorder	0.000122	0.000295	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COMT—bipolar disorder	0.000121	0.000292	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOA—bipolar disorder	0.00012	0.00029	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADCY2—bipolar disorder	0.000109	0.000263	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—bipolar disorder	9.76e-05	0.000236	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—bipolar disorder	9.75e-05	0.000236	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—bipolar disorder	9.71e-05	0.000235	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COMT—bipolar disorder	9.31e-05	0.000225	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOA—bipolar disorder	9.24e-05	0.000224	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—bipolar disorder	7.79e-05	0.000189	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—bipolar disorder	7.75e-05	0.000188	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—bipolar disorder	7.52e-05	0.000182	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—bipolar disorder	6.02e-05	0.000146	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—bipolar disorder	5.98e-05	0.000145	CbGpPWpGaD
